Analysis Demonstrates Effectiveness of LY-CoV555 Antibody in Preventing Symptomatic COVID-19
January 25, 2021 17:59 ET
|
COVID-19 Prevention Network
DURHAM, N.C., Jan. 25, 2021 (GLOBE NEWSWIRE) -- Researchers from the COVID-19 Prevention Network (CoVPN) announced that the monoclonal antibody (mAb), LY-CoV555 (bamlanivimab), evaluated in...